Cargando…

Triplet repeat RNA structure and its role as pathogenic agent and therapeutic target

This review presents detailed information about the structure of triplet repeat RNA and addresses the simple sequence repeats of normal and expanded lengths in the context of the physiological and pathogenic roles played in human cells. First, we discuss the occurrence and frequency of various trinu...

Descripción completa

Detalles Bibliográficos
Autores principales: Krzyzosiak, Wlodzimierz J., Sobczak, Krzysztof, Wojciechowska, Marzena, Fiszer, Agnieszka, Mykowska, Agnieszka, Kozlowski, Piotr
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Oxford University Press 2012
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3245940/
https://www.ncbi.nlm.nih.gov/pubmed/21908410
http://dx.doi.org/10.1093/nar/gkr729
_version_ 1782219911269974016
author Krzyzosiak, Wlodzimierz J.
Sobczak, Krzysztof
Wojciechowska, Marzena
Fiszer, Agnieszka
Mykowska, Agnieszka
Kozlowski, Piotr
author_facet Krzyzosiak, Wlodzimierz J.
Sobczak, Krzysztof
Wojciechowska, Marzena
Fiszer, Agnieszka
Mykowska, Agnieszka
Kozlowski, Piotr
author_sort Krzyzosiak, Wlodzimierz J.
collection PubMed
description This review presents detailed information about the structure of triplet repeat RNA and addresses the simple sequence repeats of normal and expanded lengths in the context of the physiological and pathogenic roles played in human cells. First, we discuss the occurrence and frequency of various trinucleotide repeats in transcripts and classify them according to the propensity to form RNA structures of different architectures and stabilities. We show that repeats capable of forming hairpin structures are overrepresented in exons, which implies that they may have important functions. We further describe long triplet repeat RNA as a pathogenic agent by presenting human neurological diseases caused by triplet repeat expansions in which mutant RNA gains a toxic function. Prominent examples of these diseases include myotonic dystrophy type 1 and fragile X-associated tremor ataxia syndrome, which are triggered by mutant CUG and CGG repeats, respectively. In addition, we discuss RNA-mediated pathogenesis in polyglutamine disorders such as Huntington's disease and spinocerebellar ataxia type 3, in which expanded CAG repeats may act as an auxiliary toxic agent. Finally, triplet repeat RNA is presented as a therapeutic target. We describe various concepts and approaches aimed at the selective inhibition of mutant transcript activity in experimental therapies developed for repeat-associated diseases.
format Online
Article
Text
id pubmed-3245940
institution National Center for Biotechnology Information
language English
publishDate 2012
publisher Oxford University Press
record_format MEDLINE/PubMed
spelling pubmed-32459402012-01-03 Triplet repeat RNA structure and its role as pathogenic agent and therapeutic target Krzyzosiak, Wlodzimierz J. Sobczak, Krzysztof Wojciechowska, Marzena Fiszer, Agnieszka Mykowska, Agnieszka Kozlowski, Piotr Nucleic Acids Res Survey and Summary This review presents detailed information about the structure of triplet repeat RNA and addresses the simple sequence repeats of normal and expanded lengths in the context of the physiological and pathogenic roles played in human cells. First, we discuss the occurrence and frequency of various trinucleotide repeats in transcripts and classify them according to the propensity to form RNA structures of different architectures and stabilities. We show that repeats capable of forming hairpin structures are overrepresented in exons, which implies that they may have important functions. We further describe long triplet repeat RNA as a pathogenic agent by presenting human neurological diseases caused by triplet repeat expansions in which mutant RNA gains a toxic function. Prominent examples of these diseases include myotonic dystrophy type 1 and fragile X-associated tremor ataxia syndrome, which are triggered by mutant CUG and CGG repeats, respectively. In addition, we discuss RNA-mediated pathogenesis in polyglutamine disorders such as Huntington's disease and spinocerebellar ataxia type 3, in which expanded CAG repeats may act as an auxiliary toxic agent. Finally, triplet repeat RNA is presented as a therapeutic target. We describe various concepts and approaches aimed at the selective inhibition of mutant transcript activity in experimental therapies developed for repeat-associated diseases. Oxford University Press 2012-01 2011-09-09 /pmc/articles/PMC3245940/ /pubmed/21908410 http://dx.doi.org/10.1093/nar/gkr729 Text en © The Author(s) 2011. Published by Oxford University Press. http://creativecommons.org/licenses/by-nc/3.0 This is an Open Access article distributed under the terms of the Creative Commons Attribution Non-Commercial License (http://creativecommons.org/licenses/by-nc/3.0), which permits unrestricted non-commercial use, distribution, and reproduction in any medium, provided the original work is properly cited.
spellingShingle Survey and Summary
Krzyzosiak, Wlodzimierz J.
Sobczak, Krzysztof
Wojciechowska, Marzena
Fiszer, Agnieszka
Mykowska, Agnieszka
Kozlowski, Piotr
Triplet repeat RNA structure and its role as pathogenic agent and therapeutic target
title Triplet repeat RNA structure and its role as pathogenic agent and therapeutic target
title_full Triplet repeat RNA structure and its role as pathogenic agent and therapeutic target
title_fullStr Triplet repeat RNA structure and its role as pathogenic agent and therapeutic target
title_full_unstemmed Triplet repeat RNA structure and its role as pathogenic agent and therapeutic target
title_short Triplet repeat RNA structure and its role as pathogenic agent and therapeutic target
title_sort triplet repeat rna structure and its role as pathogenic agent and therapeutic target
topic Survey and Summary
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3245940/
https://www.ncbi.nlm.nih.gov/pubmed/21908410
http://dx.doi.org/10.1093/nar/gkr729
work_keys_str_mv AT krzyzosiakwlodzimierzj tripletrepeatrnastructureanditsroleaspathogenicagentandtherapeutictarget
AT sobczakkrzysztof tripletrepeatrnastructureanditsroleaspathogenicagentandtherapeutictarget
AT wojciechowskamarzena tripletrepeatrnastructureanditsroleaspathogenicagentandtherapeutictarget
AT fiszeragnieszka tripletrepeatrnastructureanditsroleaspathogenicagentandtherapeutictarget
AT mykowskaagnieszka tripletrepeatrnastructureanditsroleaspathogenicagentandtherapeutictarget
AT kozlowskipiotr tripletrepeatrnastructureanditsroleaspathogenicagentandtherapeutictarget